Why responses to immune checkpoint inhibitors are heterogeneous in head and neck cancers: Contributions from tumor-intrinsic and host-intrinsic factors

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment including in head and neck squamous cell carcinomas (HNSCCs); however, only a fraction of HNSCC patients respond to ICI, whereas the majority fail to do so. The mechanisms underlying such variable responses remain incompletely...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhangguo, John, Jessy, Wang, Jing H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623029/
https://www.ncbi.nlm.nih.gov/pubmed/36330485
http://dx.doi.org/10.3389/fonc.2022.995434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623029/
https://www.ncbi.nlm.nih.gov/pubmed/36330485
http://dx.doi.org/10.3389/fonc.2022.995434

Ejemplares similares